Guggenheim Capital’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$967K Sell
12,962
-222
-2% -$16.6K 0.01% 893
2025
Q1
$838K Sell
13,184
-229
-2% -$14.6K 0.01% 952
2024
Q4
$1.05M Sell
13,413
-412
-3% -$32.2K 0.01% 895
2024
Q3
$1.11M Sell
13,825
-135
-1% -$10.9K 0.01% 1043
2024
Q2
$1.15M Sell
13,960
-670
-5% -$55.4K 0.01% 1043
2024
Q1
$1.25M Buy
14,630
+3,446
+31% +$294K 0.01% 1087
2023
Q4
$956K Buy
11,184
+2,132
+24% +$182K 0.01% 1182
2023
Q3
$811K Buy
+9,052
New +$811K 0.01% 1197
2023
Q1
Sell
-10,459
Closed -$823K 1951
2022
Q4
$823K Sell
10,459
-1,619
-13% -$127K 0.01% 1260
2022
Q3
$894K Sell
12,078
-132
-1% -$9.77K 0.01% 1191
2022
Q2
$795K Sell
12,210
-657
-5% -$42.8K 0.01% 1335
2022
Q1
$814K Buy
12,867
+525
+4% +$33.2K ﹤0.01% 1466
2021
Q4
$655K Sell
12,342
-1,455
-11% -$77.2K ﹤0.01% 1553
2021
Q3
$974K Buy
13,797
+2,554
+23% +$180K 0.01% 1428
2021
Q2
$749K Buy
11,243
+1,894
+20% +$126K ﹤0.01% 1639
2021
Q1
$1.04M Buy
9,349
+5,675
+154% +$630K 0.01% 1376
2020
Q4
$436K Buy
+3,674
New +$436K ﹤0.01% 1687
2020
Q2
Sell
-2,359
Closed -$235K 1902
2020
Q1
$235K Sell
2,359
-872
-27% -$86.9K ﹤0.01% 1615
2019
Q4
$371K Sell
3,231
-2,456
-43% -$282K ﹤0.01% 1728
2019
Q3
$717K Buy
5,687
+1,229
+28% +$155K 0.01% 1469
2019
Q2
$536K Sell
4,458
-424
-9% -$51K ﹤0.01% 1624
2019
Q1
$427K Sell
4,882
-681
-12% -$59.6K ﹤0.01% 1756
2018
Q4
$557K Buy
+5,563
New +$557K ﹤0.01% 1631
2014
Q4
Sell
-5,938
Closed -$208K 3028
2014
Q3
$208K Buy
5,938
+191
+3% +$6.69K ﹤0.01% 2777
2014
Q2
$202K Sell
5,747
-426
-7% -$15K ﹤0.01% 2858
2014
Q1
$202K Buy
+6,173
New +$202K ﹤0.01% 2828
2013
Q4
Sell
-7,813
Closed -$312K 3138
2013
Q3
$312K Sell
7,813
-48
-0.6% -$1.92K ﹤0.01% 2532
2013
Q2
$325K Buy
+7,861
New +$325K ﹤0.01% 2511